Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-01-12

Clinical Trial Update: Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer [NA]

View source ↗

Summary

Clinical trial status update indicating a study evaluating chemotherapy with or without IMD10 (focused ultrasound) for border-line resectable or locally advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (chemotherapy)
  • IMD10 (Focused Ultrasound) (Focused ultrasound device)

Snippet

Sponsor: IMGT Co., Ltd. | Conditions: Pancreatic Cancer, Borderline Resectable Pancreatic Cancer | NA | Status: NOT_YET_RECRUITING